Home » Boston Scientific Issues Updates on Vessix Renal Denervation Studies
Boston Scientific Issues Updates on Vessix Renal Denervation Studies
Boston Scientific touted its newly acquired Vessix Vascular renal denervation system, releasing interim reports from the REDUCE-HTN clinical trial during the Transcatheter Cardiovascular Therapeutics conference in San Francisco.
MassDevice
MassDevice
Upcoming Events
-
07May
-
14May
-
30May